Intrathecal injection of a single dose of Ziconotide (Prialt) to evaluate the option of continuous administration via implanted pump. A Pilot Study.

Trial Profile

Intrathecal injection of a single dose of Ziconotide (Prialt) to evaluate the option of continuous administration via implanted pump. A Pilot Study.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Jun 2013

At a glance

  • Drugs Ziconotide (Primary)
  • Indications Musculoskeletal pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Mar 2012 Actual initiation date (21 Oct 2009) added as reported by European Clinical Trials Database.
    • 18 Nov 2011 United Kingdom Clinical Research Network reports accrual to date changed from 90% to 100%.
    • 18 Nov 2011 Planned End Date changed from 31 May 2011 to 14 Jun 2011 as reported by United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top